Cargando…
Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5
The small molecule citrate is a key molecule that is synthesized de novo and involved in diverse biochemical pathways influencing cell metabolism and function. Citrate is highly abundant in the circulation, and cells take up extracellular citrate via the sodium-dependent plasma membrane transporter...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054676/ https://www.ncbi.nlm.nih.gov/pubmed/36984771 http://dx.doi.org/10.3390/metabo13030331 |
_version_ | 1785015728357769216 |
---|---|
author | Chen, Fangfang Willenbockel, Hanna Friederike Cordes, Thekla |
author_facet | Chen, Fangfang Willenbockel, Hanna Friederike Cordes, Thekla |
author_sort | Chen, Fangfang |
collection | PubMed |
description | The small molecule citrate is a key molecule that is synthesized de novo and involved in diverse biochemical pathways influencing cell metabolism and function. Citrate is highly abundant in the circulation, and cells take up extracellular citrate via the sodium-dependent plasma membrane transporter NaCT encoded by the SLC13A5 gene. Citrate is critical to maintaining metabolic homeostasis and impaired NaCT activity is implicated in metabolic disorders. Though citrate is one of the best known and most studied metabolites in humans, little is known about the consequences of altered citrate uptake and metabolism. Here, we review recent findings on SLC13A5, NaCT, and citrate metabolism and discuss the effects on metabolic homeostasis and SLC13A5-dependent phenotypes. We discuss the “multiple-hit theory” and how stress factors induce metabolic reprogramming that may synergize with impaired NaCT activity to alter cell fate and function. Furthermore, we underline how citrate metabolism and compartmentalization can be quantified by combining mass spectrometry and tracing approaches. We also discuss species-specific differences and potential therapeutic implications of SLC13A5 and NaCT. Understanding the synergistic impact of multiple stress factors on citrate metabolism may help to decipher the disease mechanisms associated with SLC13A5 citrate transport disorders. |
format | Online Article Text |
id | pubmed-10054676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100546762023-03-30 Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 Chen, Fangfang Willenbockel, Hanna Friederike Cordes, Thekla Metabolites Review The small molecule citrate is a key molecule that is synthesized de novo and involved in diverse biochemical pathways influencing cell metabolism and function. Citrate is highly abundant in the circulation, and cells take up extracellular citrate via the sodium-dependent plasma membrane transporter NaCT encoded by the SLC13A5 gene. Citrate is critical to maintaining metabolic homeostasis and impaired NaCT activity is implicated in metabolic disorders. Though citrate is one of the best known and most studied metabolites in humans, little is known about the consequences of altered citrate uptake and metabolism. Here, we review recent findings on SLC13A5, NaCT, and citrate metabolism and discuss the effects on metabolic homeostasis and SLC13A5-dependent phenotypes. We discuss the “multiple-hit theory” and how stress factors induce metabolic reprogramming that may synergize with impaired NaCT activity to alter cell fate and function. Furthermore, we underline how citrate metabolism and compartmentalization can be quantified by combining mass spectrometry and tracing approaches. We also discuss species-specific differences and potential therapeutic implications of SLC13A5 and NaCT. Understanding the synergistic impact of multiple stress factors on citrate metabolism may help to decipher the disease mechanisms associated with SLC13A5 citrate transport disorders. MDPI 2023-02-23 /pmc/articles/PMC10054676/ /pubmed/36984771 http://dx.doi.org/10.3390/metabo13030331 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chen, Fangfang Willenbockel, Hanna Friederike Cordes, Thekla Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title | Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title_full | Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title_fullStr | Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title_full_unstemmed | Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title_short | Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5 |
title_sort | mapping the metabolic niche of citrate metabolism and slc13a5 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054676/ https://www.ncbi.nlm.nih.gov/pubmed/36984771 http://dx.doi.org/10.3390/metabo13030331 |
work_keys_str_mv | AT chenfangfang mappingthemetabolicnicheofcitratemetabolismandslc13a5 AT willenbockelhannafriederike mappingthemetabolicnicheofcitratemetabolismandslc13a5 AT cordesthekla mappingthemetabolicnicheofcitratemetabolismandslc13a5 |